{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T08:43:18Z","timestamp":1784191398888,"version":"3.55.0"},"reference-count":23,"publisher":"FapUNIFESP (SciELO)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Soc. Bras. Med. Trop."],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1590\/0037-8682-0455-2016","type":"journal-article","created":{"date-parts":[[2017,3,16]],"date-time":"2017-03-16T14:48:31Z","timestamp":1489675711000},"page":"67-74","source":"Crossref","is-referenced-by-count":17,"title":["Efficacy and safety of amphotericin B deoxycholate versus N-methylglucamine antimoniate in pediatric visceral leishmaniasis: an open-label, randomized, and controlled pilot trial in Brazil"],"prefix":"10.1590","volume":"50","author":[{"given":"Myrlena Mescouto","family":"Borges","sequence":"first","affiliation":[{"name":"Universidade Federal do Tocantins,  Brazil; Universidade de Bras\u00edlia,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Cristina da Silva","family":"Pranchevicius","sequence":"additional","affiliation":[{"name":"Universidade Federal do Tocantins,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elza Ferreira","family":"Noronha","sequence":"additional","affiliation":[{"name":"Universidade de Bras\u00edlia,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo Adolfo Sierra","family":"Romero","sequence":"additional","affiliation":[{"name":"Universidade de Bras\u00edlia,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9sar Omar","family":"Carranza-Tamayo","sequence":"additional","affiliation":[{"name":"Universidade de Bras\u00edlia,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","reference":[{"issue":"(4)","key":"ref1","first-page":"644","article-title":"Geographic spread of visceral leishmaniasis in Brazil","volume":"26","author":"Werneck GL","year":"2010","journal-title":"Cad Sa\u00fade P\u00fablica"},{"issue":"(1)","key":"ref2","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ijantimicag.2004.09.011","article-title":"Treatment of pediatric visceral leishmaniasis: amphotericin B or pentavalent antimony compounds?","volume":"25","author":"Kafetzis DA","year":"2005","journal-title":"Int J Antimicrob Agents"},{"issue":"(1)","key":"ref3","article-title":"Control of visceral leishmaniasis in Latin America - A systematic review","volume":"4","author":"Romero GAS","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"ref4","series-title":"Casos confirmados de Leishmaniose Visceral, Brasil, Grandes Regi\u00f5es e Unidades Federadas. 1990 a 2014","year":"2016"},{"issue":"(6)","key":"ref5","first-page":"735","article-title":"Cytokines and visceral leishmaniasis: a comparison of plasma cytokine profiles between the clinical forms of visceral leishmaniasis","volume":"107","author":"Andrade ASS","year":"2012","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"ref6","series-title":"Fatores associados \u00e0 evolu\u00e7\u00e3o cl\u00ednica da leishmaniose visceral em crian\u00e7as hospitalizadas em centro de refer\u00eancia de Belo Horizonte, 2001 a 2005","author":"Braga ASC","year":"2007"},{"issue":"(3)","key":"ref7","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1590\/0037-8682-0138-2015","article-title":"New delivery systems for amphotericin B applied to the improvement of leishmaniasis treatment","volume":"48","author":"Ch\u00e1vez-Fumagalli MA","year":"2015","journal-title":"Rev Soc Bras Med Trop"},{"key":"ref8","series-title":"MS amplia indica\u00e7\u00e3o de medicamento para o tratamento da leishmaniose visceral","year":"2014"},{"issue":"(5)","key":"ref9","first-page":"593","article-title":"Studies on malnutrition in children","volume":"8","author":"G\u00f3mez F","year":"1951","journal-title":"Bol Med Hosp Infant Mex"},{"issue":"(7)","key":"ref10","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.trstmh.2009.01.014","article-title":"Prevalence of Leishmania infection in adult HIV\/AIDS patients treated in a tertiary-level care center in Brasilia, Federal District, Brazil","volume":"103","author":"Carranza-Tamayo CO","year":"2009","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref11","series-title":"Table for Grading the Severity of Adult and Pediatric Adverse Events","year":"2014","edition":"Version 2.0"},{"key":"ref12","series-title":"Clinical trials: a practical approach","first-page":"123","volume-title":"The size of a clinical trial","author":"Pocock SJ","year":"1983"},{"issue":"(2)","key":"ref13","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1590\/S1413-81232010000200002","article-title":"A crian\u00e7a \u00e9 o pai do homem: novos desafios para a \u00e1rea de sa\u00fade da crian\u00e7a","volume":"15","author":"Moreira MEL","year":"2010","journal-title":"Cien Sa\u00fade Colet"},{"issue":"(1)","key":"ref14","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0035-9203(88)90267-2","article-title":"Pharmokinetics of antimony during treatment of visceral leishmaniaisis with sodium stibogluconate or meglumine antimoniate","volume":"8","author":"Chulay JD","year":"1988","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"(2)","key":"ref15","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-3156.2006.01782.x","article-title":"Drug policy for visceral leishmaniasis: a cost-effectiveness analysis","volume":"12","author":"Vanlerberghe V","year":"2007","journal-title":"Trop Med Int Health"},{"issue":"(5)","key":"ref16","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1086\/367843","article-title":"Two doses of a lipid formulation of amphotericin B for the treatment of Mediterranean visceral leishmaniasis","volume":"36","author":"Syriopoulou V","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"(4)","key":"ref17","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/516526","article-title":"Response to interferon-\u03b3 plus pentavalent antimony in Indian visceral leishmaniasis","volume":"176","author":"Sundar S","year":"1997","journal-title":"J Infect Dis"},{"issue":"(4)","key":"ref18","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S0035-9203(00)90131-7","article-title":"Treatment of visceral leishmaniasis with injectable paromomycin (aminosidine). An open-label randomized phase-II clinical study","volume":"94","author":"Thakur CP","year":"2000","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"(12)","key":"ref19","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1007\/BF02763048","article-title":"Miltefosine in children with visceral leishmaniasis: a prospective, multicentric, cross-sectional study","volume":"73","author":"Singh UK","year":"2006","journal-title":"Indian J Pediatr"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/j.trstmh.2006.02.011","article-title":"Oral miltefosine for the treatment of Indian visceral leishmaniasis","volume":"100","author":"Sundar S","year":"2006","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"(2)","key":"ref21","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/myc.12283","article-title":"Comparison of nephrotoxicity associated to different lipid formulations of amphotericin B: a real-life study","volume":"58","author":"Falci DR","year":"2015","journal-title":"Mycoses"},{"issue":"(8937)","key":"ref22","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/S0140-6736(94)90406-5","article-title":"Amphotericin versus sodium stibogluconate in first-line treatment of Indian kala-azar","volume":"344","author":"Mishra M","year":"1994","journal-title":"Lancet"},{"issue":"(4)","key":"ref23","first-page":"378","article-title":"Liposomal amphotericin B versus pentavalent antimony salts for visceral Leishmania in children","volume":"55","author":"Apa H","year":"2013","journal-title":"Turk J Pediatr"}],"container-title":["Revista da Sociedade Brasileira de Medicina Tropical"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/rsbmt\/v50n1\/0037-8682-rsbmt-50-01-00067.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,12,30]],"date-time":"2017-12-30T22:02:54Z","timestamp":1514671374000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0037-86822017000100067&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S0037-86822017000100067"],"URL":"https:\/\/doi.org\/10.1590\/0037-8682-0455-2016","relation":{},"ISSN":["1678-9849","0037-8682"],"issn-type":[{"value":"1678-9849","type":"electronic"},{"value":"0037-8682","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]}}}